A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.

Why are some filings missing?

New filings appear as the SEC updates EDGAR, and older records can vary by availability.

How often is this page updated?

Updates follow new EDGAR submissions and periodic data refreshes.

SEC EDGAR filings, ownership reports, and insider transactions for Tina Marie deVries.

Business address: C/O Osmotica Pharmaceuticals Plc, 400 Crossing Boulevard, Bridgewater, NJ, 08807
Top holdings (ownership): RVLP

Get insider transactions for this reporting owner

Tina Marie deVries has filed 9 SEC EDGAR filings since 18 Oct 2018

Recent SEC filings for Tina Marie deVries including 4, 3.

Form type	Document	Filing	Description	Filing date	Reporting date	File number(s)
4	Open 4 document	View SEC filing for 4	OWNERSHIP DOCUMENT	20 May 2022	18 May 2022	001-38709
4	Open 4 document	View SEC filing for 4	OWNERSHIP DOCUMENT	26 Jan 2022	24 Jan 2022	001-38709
4	Open 4 document	View SEC filing for 4	OWNERSHIP DOCUMENT	08 Nov 2021	04 Nov 2021	001-38709
4	Open 4 document	View SEC filing for 4	OWNERSHIP DOCUMENT	20 May 2021	18 May 2021	001-38709
4	Open 4 document	View SEC filing for 4	OWNERSHIP DOCUMENT	26 Jan 2021	24 Jan 2021	001-38709
4	Open 4 document	View SEC filing for 4	4	20 May 2020	18 May 2020	001-38709
4	Open 4 document	View SEC filing for 4	4	30 Jan 2020	28 Jan 2020	001-38709
4	Open 4 document	View SEC filing for 4	4	28 Jan 2019	24 Jan 2019	001-38709
3	Open 3 document	View SEC filing for 3	3	18 Oct 2018	18 Oct 2018	001-38709

Tina Marie deVries files with the SEC under CIK 0001750589. This page aggregates EDGAR filings and related ownership activity.

What is a CIK?: A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?: New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?: Updates follow new EDGAR submissions and periodic data refreshes.